Contact this trialFirst, we need to learn more about you.
Procedure
Red Blood Cell Survival Study for Sickle Cell Disease
Recruiting1 awardPhase 1
Atlanta, Georgia
This trial aims to understand how long transfused red blood cells (RBCs) last in patients with sickle cell disease (SCD) who receive frequent blood transfusions. Researchers will label a small portion of the transfused RBCs with biotin to track their survival. The study will help identify factors that influence the effectiveness of these transfusions and improve treatment strategies.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service